• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Health Canada licenses Medtronic Guardian 4 CGM sensor for use with MiniMed 780G

May 4, 2023 By Sean Whooley

MiniMed 780G with Guardian 4 Medtronic
The MiniMed 780G with the Guardian 4 sensor. [Image courtesy of Medtronic]
Medtronic (NYSE:MDT) announced that it received a license from Health Canada for use of its Guardian 4 with the MiniMed 780G.

The licensing enables the use of the next-generation continuous glucose monitor sensor with the next-generation automated insulin pump. MiniMed 780G with Guardian 4, an advanced, hybrid closed-loop system, helps users manage type 1 diabetes.

Health Canada licensing comes on the heels of FDA approval for the MiniMed 780G with Guardian 4. The system requires no fingersticks while in SmartGuard mode. It offers meal detection technology, providing automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs.

MiniMed 780G with Guardian 4 offers insulin to account for when users forget to bolus or underestimate the number of carbs in their meal.

Medtronic expects to launch the new sensor in Canada by the end of 2023. Canadian officials previously approved the MiniMed 780G pump in November 2022.

“With the recent launch of the world’s first and only insulin pump system with meal detection technology, we are hearing from our MiniMed 780G system users that it’s helping increase their time in range and the improved usability of our system is already making a significant impact on their day-to-day lives,” said Laura Cameron, senior director of endocrinology at Medtronic Canada. “We’re thrilled to expand our innovative solutions that help simplify diabetes management with the goal of making lives easier for those we have the privilege to support.”

Que Dallara, Medtronic Diabetes EVP and president, and Ali Dianaty, VP of product innovation, spoke with Drug Delivery Business News following the system’s FDA approval. Read about it here.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Health Canada, Medtronic

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS